» Articles » PMID: 39513893

Eosinophil-Basophil/Lymphocyte (EB/LR) and Eosinophil-Basophil-Platelet/Lymphocyte (EBP/LR) Ratios Could Serve As Useful Additional Markers for Assessing the Severity of Wasp Allergic Reactions

Overview
Journal Cells
Publisher MDPI
Date 2024 Nov 8
PMID 39513893
Authors
Affiliations
Soon will be listed here.
Abstract

Wasp venom allergy can trigger severe allergic reactions, and predicting these acute responses remains challenging. This study evaluates the utility of immune system indexes, particularly the eosinophil-basophil/lymphocyte (EB/LR) and eosinophil-basophil-platelet/lymphocyte (EBP/LR) ratios, in assessing the severity of allergic reactions in patients with wasp venom allergy. A total of 61 patients with confirmed wasp venom allergy were categorized according to the Mueller scale, which classifies the severity of allergic reactions. Blood samples were analyzed for total and specific IgE levels alongside a range of hematological and biochemical parameters. This study found significant differences in the EB/LR and EBP/LR indexes between patients with mild (Mueller I-II) and severe (Mueller III-IV) allergic reactions, with higher values indicating more severe responses. However, no significant differences were observed in other immune indexes, such as the platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, and systemic inflammatory response index, as well as in additional blood parameters. These findings suggest that the EB/LR and EBP/LR ratios may serve as useful markers for predicting the severity of allergic reactions in patients with wasp venom allergy. This is the first study to establish such a link, although further research with larger cohorts is necessary to confirm these results and their potential application in clinical settings.

References
1.
Wang S, Pan X, Jia B, Chen S . Exploring the Correlation Between the Systemic Immune Inflammation Index (SII), Systemic Inflammatory Response Index (SIRI), and Type 2 Diabetic Retinopathy. Diabetes Metab Syndr Obes. 2023; 16:3827-3836. PMC: 10683512. DOI: 10.2147/DMSO.S437580. View

2.
Lee J, Lozano-Ruiz B, Yang F, Fan D, Shen L, Gonzalez-Navajas J . The Multifaceted Role of Th1, Th9, and Th17 Cells in Immune Checkpoint Inhibition Therapy. Front Immunol. 2021; 12:625667. PMC: 7994325. DOI: 10.3389/fimmu.2021.625667. View

3.
Warrington R . Lack of Correlation between Severity of Clinical Symptoms, Skin Test Reactivity, and Radioallergosorbent Test Results in Venom-Allergic Patients. Allergy Asthma Clin Immunol. 2010; 2(2):62-7. PMC: 2876184. DOI: 10.1186/1710-1492-2-2-62. View

4.
Day J, Buckeridge D, Welsh A . Risk assessment in determining systemic reactivity to honeybee stings in sting-threatened individuals. J Allergy Clin Immunol. 1994; 93(4):691-705. DOI: 10.1016/0091-6749(94)90249-6. View

5.
Graif Y, Romano-Zelekha O, Livne I, Green M, Shohat T . Increased rate and greater severity of allergic reactions to insect sting among schoolchildren with atopic diseases. Pediatr Allergy Immunol. 2009; 20(8):757-62. DOI: 10.1111/j.1399-3038.2009.00863.x. View